Japan Approves Janssen’s COVID Jab, Sanofi’s Sutimlimab, Olumiant’s Alopecia Use and More

Japan health ministry approved a batch of new medicines and indications on June 20 including Janssen Pharmaceutical’s COVID-19 vaccine Jcovden and Sanofi’s anti-C1s monoclonal antibody Enjaymo (sutimlimab). Jcovden, a recombinant vector vaccine, has now become the fifth jab approved in...read more